CoChat

Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver

Open access
Fu, Xiaorong, Fletcher, Justin A., Deja, Stanisław, Inigo-Vollmer, Melissa, Burgess, Shawn C., Browning, Jeffrey D. · 2023 · Journal of Clinical Investigation

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Abstract

BACKGROUNDHepatic de novo lipogenesis (DNL) and β-oxidation are tightly coordinated, and their dysregulation is thought to contribute to the pathogenesis of nonalcoholic fatty liver (NAFL). Fasting normally relaxes DNL-mediated inhibition of hepatic β-oxidation, dramatically increasing ketogenesis and decreasing reliance on the TCA cycle. Thus, we tested whether aberrant oxidative metabolism in fasting NAFL subjects is related to the inability to halt fasting DNL.METHODSForty consecutive nondiabetic individuals with and without a history of NAFL were recruited for this observational study. After phenotyping, subjects fasted for 24 hours, and hepatic metabolism was interrogated using a combination of 2H2O and 13C tracers, magnetic resonance spectroscopy, and high-resolution mass spectrometry.RESULTSWithin a subset of subjects, DNL was detectable after a 24-hour fast and was more prominent in those with NAFL, though it was poorly correlated with steatosis. However, fasting DNL negatively correlated with hepatic β-oxidation and ketogenesis and positively correlated with citrate synthesis. Subjects with NAFL but undetectable fasting DNL (25th percentile) were comparatively normal. However, those with the highest fasting DNL (75th percentile) were intransigent to the effects of fasting on the concentration of insulin, non-esterified fatty acid, and ketones. Additionally, they sustained glycogenolysis and were spared the loss of oxaloacetate to gluconeogenesis in favor of citrate synthesis, which correlated with DNL and diminished ketogenesis.CONCLUSIONMetabolic flux analysis in fasted subjects indicates that shared metabolic mechanisms link the dysregulations of hepatic DNL, ketogenesis, and the TCA cycle in NAFL.TRIAL REGISTRATIONData were obtained during the enrollment/non-intervention phase of Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease, ClinicalTrials.gov NCT02690792.FUNDINGThis work was supported by the University of Texas Southwestern NORC Quantitative Metabolism Core (NIH P30DK127984), the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078184, R01DK128168, R01DK087977, R01DK132254, and K01DK133630), the NIH/National Institute on Alcohol Abuse and Alcoholism (K01AA030327), and the Robert A. Welch Foundation (I-1804).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci167442

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 DNL persists after a 24-hour fast in some subjects. (A) Study schema. (B) High-resolution Orbitrap gas chromatography–mass spectrometry (MS) of palmitate isolated from plasma TG of humans with various degrees of fasting DNL. The 2H M+1 enrichment was easily resolved from the M+1 of 13C and was used to determine DNL. (C) Fractional DNL in overnight- (n = 4) and 24-hour-fasted (n = 40) subjects. (D) Percentage body fat, measured by DEXA, in DNL(–) (n = 13) and DNL(+) (n = 27) subjects. (E) Liver triglyceride (TG) measured by 1H-MRS. (F) Plasma TGs. (G and H) Subjects without NAFL (Non-NAFL) were dichotomized by the presence or absence of persistent fasting DNL. NAFL subjects were ranked according to fasting DNL activity and divided into quartiles (Q1, lower 25th percentile; Q2, middle 25th to 75th percentile; Q3, upper 75th percentile). (I) Hepatic TG content across the range of fasting DNL. (J) Plasma TG across the spectrum of fasting DNL. Statistical significance was determined by 2-tailed t test, 1-way ANOVA to analyze multiple groups, and Pearson correlation. Non-correlative data are presented as mean ± SEM.
Figure 1 DNL persists after a 24-hour fast in some subjects. (A) Study schema. (B) High-resolution Orbitrap gas chromatography–mass spectrometry (MS) of palmitate isolated from plasma TG of humans with various degrees of fasting DNL. The 2H M+1 enrichment was easily resolved from the M+1 of 13C and was used to determine DNL. (C) Fractional DNL in overnight- (n = 4) and 24-hour-fasted (n = 40) subjects. (D) Percentage body fat, measured by DEXA, in DNL(–) (n = 13) and DNL(+) (n = 27) subjects. (E) Liver triglyceride (TG) measured by 1H-MRS. (F) Plasma TGs. (G and H) Subjects without NAFL (Non-NAFL) were dichotomized by the presence or absence of persistent fasting DNL. NAFL subjects were ranked according to fasting DNL activity and divided into quartiles (Q1, lower 25th percentile; Q2, middle 25th to 75th percentile; Q3, upper 75th percentile). (I) Hepatic TG content across the range of fasting DNL. (J) Plasma TG across the spectrum of fasting DNL. Statistical significance was determined by 2-tailed t test, 1-way ANOVA to analyze multiple groups, and Pearson correlation. Non-correlative data are presented as mean ± SEM.CC BY · PubMed Central
Figure 2 Fasting DNL in NAFL subjects is associated with lower ketogenesis and β-oxidation, but increased TCA cycle flux, which preserves estimated hepatic oxygen consumption. (A) Correlation between fasting DNL and ketogenesis measured by in vivo ketone turnover (n = 38), with comparison between subjects without NAFL (non-NAFL) and no DNL [DNL(–)] and NAFL subjects with the highest DNL (Q3). (B) Correlation between fasting DNL and TCA cycle flux measured by in vivo 13C and 2H isotopomer analysis of plasma glucose (n = 38), with comparison between DNL(–) and Q3 subjects. (C) Correlation between fasting DNL and the fraction of acetyl-CoA partitioned to the TCA cycle (vs. ketogenesis) (n = 36), with comparison between DNL(–) and Q3 subjects. (D) Inverse correlation between fasting DNL and the apparent rate of hepatic β-oxidation, determined as [TCA cycle flux] + [2 × ketogenesis] (n = 36), with a comparison between DNL(–) and Q3 subjects. (E) Oxygen consumption, calculated by flux balance analysis of net NADH/FADH2 production, did not correlate with fasting DNL (n = 36) and did not differ between DNL(–) and Q3 subjects. (F) Schema showing acetyl-CoA partitioning between ketogenesis and the TCA cycle during fasting DNL. The shift to TCA cycle metabolism preserves reducing equivalent flux and oxygen consumption when β-oxidation and ketogenesis are suppressed. e–, electron. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 2 for all groups). Non-correlative data are presented as mean ± SEM.
Figure 2 Fasting DNL in NAFL subjects is associated with lower ketogenesis and β-oxidation, but increased TCA cycle flux, which preserves estimated hepatic oxygen consumption. (A) Correlation between fasting DNL and ketogenesis measured by in vivo ketone turnover (n = 38), with comparison between subjects without NAFL (non-NAFL) and no DNL [DNL(–)] and NAFL subjects with the highest DNL (Q3). (B) Correlation between fasting DNL and TCA cycle flux measured by in vivo 13C and 2H isotopomer analysis of plasma glucose (n = 38), with comparison between DNL(–) and Q3 subjects. (C) Correlation between fasting DNL and the fraction of acetyl-CoA partitioned to the TCA cycle (vs. ketogenesis) (n = 36), with comparison between DNL(–) and Q3 subjects. (D) Inverse correlation between fasting DNL and the apparent rate of hepatic β-oxidation, determined as [TCA cycle flux] + [2 × ketogenesis] (n = 36), with a comparison between DNL(–) and Q3 subjects. (E) Oxygen consumption, calculated by flux balance analysis of net NADH/FADH2 production, did not correlate with fasting DNL (n = 36) and did not differ between DNL(–) and Q3 subjects. (F) Schema showing acetyl-CoA partitioning between ketogenesis and the TCA cycle during fasting DNL. The shift to TCA cycle metabolism preserves reducing equivalent flux and oxygen consumption when β-oxidation and ketogenesis are suppressed. e–, electron. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 2 for all groups). Non-correlative data are presented as mean ± SEM.CC BY · PubMed Central
Figure 3 Subjects with persistent fasting DNL are intransigent to multiple effects of fasting. Fold changes were determined from plasma/serum measurements after an overnight and a 24-hour fast. (A) Expected physiological changes in normal humans transitioning from the fed to the fasting state. (B) Correlation between fasting DNL and the fold decrease in plasma insulin during a 24-hour fast (n = 34), with comparison between subjects without NAFL (Non-NAFL) and DNL [DNL(–)] and NAFL subjects with the highest DNL (Q3). (C) Correlation between fasting DNL and the fold increase in plasma ketones during a 24-hour fast (n = 34), with comparison between DNL(–) and Q3 subjects. (D) Correlation between fasting DNL and the fold increase in plasma non-esterified fatty acids (NEFAs) during a 24-hour fast (n = 36), with comparison between DNL(–) and Q3 subjects. (E) Persistent fasting DNL among NAFL subjects blunts the normal responses of insulin, ketones, and NEFA to fasting. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 3 for all groups). Non-correlative data are presented as mean ± SEM.
Figure 3 Subjects with persistent fasting DNL are intransigent to multiple effects of fasting. Fold changes were determined from plasma/serum measurements after an overnight and a 24-hour fast. (A) Expected physiological changes in normal humans transitioning from the fed to the fasting state. (B) Correlation between fasting DNL and the fold decrease in plasma insulin during a 24-hour fast (n = 34), with comparison between subjects without NAFL (Non-NAFL) and DNL [DNL(–)] and NAFL subjects with the highest DNL (Q3). (C) Correlation between fasting DNL and the fold increase in plasma ketones during a 24-hour fast (n = 34), with comparison between DNL(–) and Q3 subjects. (D) Correlation between fasting DNL and the fold increase in plasma non-esterified fatty acids (NEFAs) during a 24-hour fast (n = 36), with comparison between DNL(–) and Q3 subjects. (E) Persistent fasting DNL among NAFL subjects blunts the normal responses of insulin, ketones, and NEFA to fasting. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 3 for all groups). Non-correlative data are presented as mean ± SEM.CC BY · PubMed Central
Figure 4 Persistent fasting DNL is associated with selective insulin resistance. (A) Correlation between fasting DNL and glucose disposal during a hyperinsulinemic-euglycemic clamp (n = 35). (B) Correlation between fasting DNL and hepatic insulin resistance (n = 35), measured as endogenous glucose production (EGP) indexed to plasma insulin. (C) Correlation between fasting DNL and ketogenic insulin resistance (n = 35), measured as endogenous ketone production indexed to plasma insulin. (D) Correlation between fasting DNL and adipose insulin resistance (IR) (n = 35), measured as plasma NEFA indexed to plasma insulin. (E) The sensitivity of DNL to insulin is represented as DNL relative to plasma insulin (n = 36). (F) Persistent fasting DNL in NAFL subjects is associated with hepatic insulin resistance in glucose and ketone production pathways but not DNL, which retains responsiveness to hyperinsulinemia. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 4 for all groups). Non-correlative data are presented as mean ± SEM.
Figure 4 Persistent fasting DNL is associated with selective insulin resistance. (A) Correlation between fasting DNL and glucose disposal during a hyperinsulinemic-euglycemic clamp (n = 35). (B) Correlation between fasting DNL and hepatic insulin resistance (n = 35), measured as endogenous glucose production (EGP) indexed to plasma insulin. (C) Correlation between fasting DNL and ketogenic insulin resistance (n = 35), measured as endogenous ketone production indexed to plasma insulin. (D) Correlation between fasting DNL and adipose insulin resistance (IR) (n = 35), measured as plasma NEFA indexed to plasma insulin. (E) The sensitivity of DNL to insulin is represented as DNL relative to plasma insulin (n = 36). (F) Persistent fasting DNL in NAFL subjects is associated with hepatic insulin resistance in glucose and ketone production pathways but not DNL, which retains responsiveness to hyperinsulinemia. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 4 for all groups). Non-correlative data are presented as mean ± SEM.CC BY · PubMed Central
Figure 5 Hepatic oxaloacetate is preferentially utilized for citrate synthesis in subjects with persistent fasting DNL. (A) The competition for oxaloacetate (OAA) by gluconeogenesis (GNG) and citrate synthase impacts the fate of acetyl-CoA. Abundant oxaloacetate facilitates citrate synthase, which outcompetes ketogenesis for acetyl-CoA. The resulting citrate is either oxidized back to oxaloacetate in the TCA cycle or transported from the mitochondria for DNL. (B and C) The absolute rate of gluconeogenesis from oxaloacetate (n = 38) (B) and glycogenolysis (n = 38) (C) was measured by glucose turnover and 2H incorporation into positions C2, C5, and C6 of plasma glucose. (D) A [U-13C3]propionate tracer was used to track oxaloacetate’s relative fate between gluconeogenesis and citrate synthesis. Anaplerosis was traced as [1,2,3-13C] or [2,3,4-13C] oxaloacetate isotopomers, which were diluted to [1,2-13C] or [3,4-13C] isotopomers upon reaction with unlabeled acetyl-CoA in the citrate synthase reaction and a subsequent turn of the TCA cycle (13). These atoms were transmitted to plasma glucose by gluconeogenesis, and isotopomers were detected by 13C-NMR and analysis of the C2 multiplets. (E) Negative correlation between fasting DNL and isotopomers arising from anaplerosis and gluconeogenesis (n = 38). (F) Positive correlation between fasting DNL and isotopomers arising from citrate synthase (n = 38). (G) Negative correlation between fasting DNL and the utilization of oxaloacetate for gluconeogenesis relative to its use by citrate synthase (n = 38). (H) Positive correlation between acetyl-CoA used for ketogenesis and the utilization of oxaloacetate for gluconeogenesis relative to its use by citrate synthase (n = 38). Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA. Non-correlative data are presented as mean ± SEM.
Figure 5 Hepatic oxaloacetate is preferentially utilized for citrate synthesis in subjects with persistent fasting DNL. (A) The competition for oxaloacetate (OAA) by gluconeogenesis (GNG) and citrate synthase impacts the fate of acetyl-CoA. Abundant oxaloacetate facilitates citrate synthase, which outcompetes ketogenesis for acetyl-CoA. The resulting citrate is either oxidized back to oxaloacetate in the TCA cycle or transported from the mitochondria for DNL. (B and C) The absolute rate of gluconeogenesis from oxaloacetate (n = 38) (B) and glycogenolysis (n = 38) (C) was measured by glucose turnover and 2H incorporation into positions C2, C5, and C6 of plasma glucose. (D) A [U-13C3]propionate tracer was used to track oxaloacetate’s relative fate between gluconeogenesis and citrate synthesis. Anaplerosis was traced as [1,2,3-13C] or [2,3,4-13C] oxaloacetate isotopomers, which were diluted to [1,2-13C] or [3,4-13C] isotopomers upon reaction with unlabeled acetyl-CoA in the citrate synthase reaction and a subsequent turn of the TCA cycle (13). These atoms were transmitted to plasma glucose by gluconeogenesis, and isotopomers were detected by 13C-NMR and analysis of the C2 multiplets. (E) Negative correlation between fasting DNL and isotopomers arising from anaplerosis and gluconeogenesis (n = 38). (F) Positive correlation between fasting DNL and isotopomers arising from citrate synthase (n = 38). (G) Negative correlation between fasting DNL and the utilization of oxaloacetate for gluconeogenesis relative to its use by citrate synthase (n = 38). (H) Positive correlation between acetyl-CoA used for ketogenesis and the utilization of oxaloacetate for gluconeogenesis relative to its use by citrate synthase (n = 38). Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA. Non-correlative data are presented as mean ± SEM.CC BY · PubMed Central
Figure 6 Elevated liver volume, but not other indices of liver function, correlates with fasting DNL. (A) Hepatic volume positively correlated with fasting DNL activity (n = 40). (B–D) Relationship between fasting DNL and plasma aspartate aminotransferase (AST) (B), alanine aminotransferase (ALT) (C), and γ-glutamyltransferase (GGT) (D) (n = 40 per panel). Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 6 for all groups). Non-correlative data are presented as mean ± SEM.
Figure 6 Elevated liver volume, but not other indices of liver function, correlates with fasting DNL. (A) Hepatic volume positively correlated with fasting DNL activity (n = 40). (B–D) Relationship between fasting DNL and plasma aspartate aminotransferase (AST) (B), alanine aminotransferase (ALT) (C), and γ-glutamyltransferase (GGT) (D) (n = 40 per panel). Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 6 for all groups). Non-correlative data are presented as mean ± SEM.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 34

Metadata

Authors
Fu, X., Fletcher, J. A., Deja, S., Inigo-Vollmer, M., Burgess, S. C., & Browning, J. D.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
Browning, Jeffrey D.
Venue
Journal of Clinical Investigation
Published
2023-05-01
Volume
133
Issue
9
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W4327626431
Cited by
30
References
53
Citations by year
2026: 6 · 2025: 13 · 2024: 8 · 2023: 3
FWCI
5.97
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (P30DK127984,R01DK078184,R01DK128168,K01DK133630,K01AA030327)
  • Robert A Welch Foundation (I-1804)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
non-alcoholic fatty liver disease, de novo lipogenesis, ketogenesis, hepatic beta-oxidation, citrate synthesis, TCA cycle, fasting, hepatic metabolism, metabolic flux, oxaloacetate, gluconeogenesis, glycogenolysis, insulin resistance, free fatty acids, ketones, steatosis, vitamin E
MeSH terms
Citrates, Fasting, Humans, Ketone Bodies, Liver, Citric Acid, Lipogenesis, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver. https://app.cochat.ai/papers/10.1172/jci167442
The paper
Fu, X., Fletcher, J. A., Deja, S., Inigo-Vollmer, M., Burgess, S. C., & Browning, J. D. (2023). Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver. Journal of Clinical Investigation. https://doi.org/10.1172/jci167442

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.